Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review Riks A. MaasHub F. J. DullensWillem Den Otter Review Pages: 141 - 148
The role of apoptosis in antibody-dependent cellular cytotoxicity S. John CurnowMartin J. GlennieGeorge T. Stevenson Original articles Pages: 149 - 155
Intratumoral interleukin-2 immunotherapy: Activation of tumor-infiltrating and splenic lymphocytes in vivo Steven M. DubinettLisa PatroneWilliam H. McBride Original articles Pages: 156 - 162
Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon α Wim M. J. VuistMarjan J. W. VisserenAnnemarie Hekman Original articles Pages: 163 - 170
Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models Barbara P. BarnaDeborah A. EppsteinSharad D. Deodhar Original articles Pages: 171 - 176
The role of monoclonal antibody A7 as a drug modifier in cancer therapy K. KitamuraT. MiyagakiT. Takahashi Original articles Pages: 177 - 184
Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen Louis M. WeinerGary R. HudesPeter J. O'Dwyer Original articles Pages: 185 - 190
Restricted T cell receptor V-β and J-β usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas Eva HalapiYasuyoshi YamamotoRolf Kiessling Original articles Pages: 191 - 197
HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients Richard A. J. JanssenJan ButerLou de Leij Original articles Pages: 198 - 204
Sex hormones and immune dysregulation in multiple myeloma Hele EverausJane Lehtmaa Original articles Pages: 205 - 209
Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer L. Th. VlasveldE. van de Wiel-van KemenadeC. G. Figdor Short communication Pages: 210 - 213